RegeneRx Biopharmaceuticals (RGRX) Stock Chart & Stock Price History $0.0002 0.00 (0.00%) As of 08/21/2025 03:57 PM Eastern Add Compare Share Share Chart Stock AnalysisChartSEC FilingsShort InterestBuy This Stock RegeneRx Biopharmaceuticals Stock Price Performance The RegeneRx Biopharmaceuticals (RGRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 85.71%, with a year-to-date return of -85.71%. In the past month, the stock has remained steady at 0.00%, reflecting recent market activity. As of the latest close, RegeneRx Biopharmaceuticals traded at $0.00 with a market cap of and volume of 350 shares. Five years ago, the stock traded at a split-adjusted price of $48.30, representing a 100.00% decrease over that period. At the time, it had a market cap of and a volume of 1,215 shares. Receive RGRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RegeneRx Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance0.00%3 Month PerformanceN/AYear-To-Date Performance-85.71%1 Year PerformanceN/A5 Year Performance-100.00% RGRX Stock Chart for Saturday, August, 23, 2025 RGRX Chart by TradingView RegeneRx Biopharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$0.00$0.00$0.00$0.00350 shs$0.0008/21/2025$0.00$0.00$0.00$0.00350 shs$0.0008/19/2025$0.00$0.00$0.00$0.00238 shs$0.0008/18/2025$0.00$0.00$0.00$0.00238 shs$0.0008/15/2025$0.12$0.00-99.83%$0.00$0.00238 shs$0.0008/14/2025$0.12$0.12$0.12$0.1213 shs$174,000.0008/13/2025$0.12$0.12$0.12$0.1233 shs$0.0008/12/2025$0.12$0.12$0.12$0.1233 shs$0.0008/11/2025$0.12$0.12$0.12$0.1233 shs$174,000.0008/08/2025$0.12$0.12$0.12$0.1233 shs$0.00 Get the Latest News and Ratings for RGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RegeneRx Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/06/2025$0.12$0.12$0.12$0.123,743 shs$0.0008/05/2025$0.00$0.12+60,400.00%$0.12$0.123,743 shs$0.0008/04/2025$0.01$0.00-96.00%$0.00$0.00243 shs$0.0008/01/2025$0.01$0.01$0.01$0.01107 shs$10,000.0007/31/2025$0.01$0.01$0.01$0.01107 shs$0.0007/30/2025$0.00$0.01+2,400.00%$0.01$0.01107 shs$0.0007/29/2025$0.00$0.00$0.00$0.00520 shs$0.0007/28/2025$0.00$0.00$0.00$0.00520 shs$0.0007/25/2025$0.00$0.00$0.00$0.002 shs$0.0007/24/2025$0.00$0.00$0.00$0.00745 shs$0.0007/23/2025$0.00$0.00$0.00$0.00745 shs$0.00 Related Companies 180 Life Sciences Stock Price Chart 4D pharma Stock Price Chart 4Front Ventures Stock Price Chart Abattis Bioceuticals Stock Price Chart Abcam Stock Price Chart Acusphere Stock Price Chart Aeolus Pharmaceuticals Stock Price Chart Aesther Healthcare Acquisition Stock Price Chart Agentix Stock Price Chart Ainos Stock Price Chart Receive RGRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RegeneRx Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:RGRX) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RegeneRx Biopharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RegeneRx Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access